Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology
Immediate Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology
1 other identifier
interventional
185
0 countries
N/A
Brief Summary
Abnormal cervical cytology was the most common reason for women being referred to the colposcopy unit. We prospectively included the women with negative cytology (negative for intraepithelial lesions or malignancy (NILM)) and positive High RiskHPV test other than HPV 16 or HPV 18. Comparing the immediate colposcopy findings among women with High Risk HPV other than HVPV16/18 and negative cytology and determine positive predictive values for CIN2+ of other high risk HPV genotypes
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2015
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
April 28, 2020
CompletedFirst Posted
Study publicly available on registry
April 30, 2020
CompletedApril 30, 2020
April 1, 2020
4.3 years
April 28, 2020
April 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dysplasia
Pathologic diagnosis of cervical dysplasia
1 month
Study Arms (2)
Other High Risk HPV Positivity
EXPERIMENTALColposcopy performed to women with High risk HPV positive ,negative for intraepithelial lesions or malignancy cytology
HPV16/18
ACTIVE COMPARATORColposcopy performed to women with HPV 16/18 positive ,negative for intraepithelial lesions or malignancy cytology
Interventions
Eligibility Criteria
You may qualify if:
- negative cytology (negative for intraepithelial lesions or malignancy (NILM)) and positive HrHPV test other than HPV 16 or HPV 18
You may not qualify if:
- Previous diagnosis for cervical cancer Previous diagnosis for vaginal cancer Previous diagnosis for cervical dysplasia Previous diagnosis for ASCUS previous history of cervical conisation or hysterectomy previous history ofhysterectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- outcomes assessor blind to clinical data and cytology results
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
April 28, 2020
First Posted
April 30, 2020
Study Start
June 1, 2015
Primary Completion
October 1, 2019
Study Completion
January 1, 2020
Last Updated
April 30, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share